Worth Venture Partners »

Terns Pharmaceuticals shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $119k 18k 6.81

More positions owned by Worth Venture Partners

Johnson & Johnson (JNJ)
Weave Communications (WEAV)
Iteris (ITI)
Pfizer (PFE)
Radcom Shs New (RDCM)
Shotspotter (SSTI)
Viking Therapeutics (VKTX)
Cto Realty Growth (CTO)
Whitestone REIT (WSR)
Equity Comwlth Com Sh Ben Int (EQC)
Epr Pptys Com Sh Ben Int (EPR)
Plymouth Indl Reit (PLYM)
Moneylion Cl A (ML)
Sezzle (SEZL)
Alnylam Pharmaceuticals Call Call Option

View all positions for Worth Venture Partners

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Deep Track Capital
Soleus Capital Management
BlackRock
BlackRock
Citadel Advisors
VR Adviser
Schonfeld Strategic Advisors
Point72 Asset Management
Vanguard Group
Avidity Partners Management
Driehaus Capital Management
ExodusPoint Capital Management
T. Rowe Price Associates
Geode Capital Management

View all funds holding Terns Pharmaceuticals